Marina Labor1,2, Slavica Labor1,2, Iva Jurić3, Vladimir Fijačko1,2, Sanja Popović Grle4, Davor Plavec2,5. 1. a Department of Pulmonology , University Hospital Center Osijek , Osijek , Croatia. 2. b Faculty of Medicine , J.J. Strossmayer University of Osijek , Osijek , Croatia. 3. c Department of Medicine , University Hospital Center Osijek , Osijek , Croatia. 4. d Department of Pulmonology , University Hospital Center Zagreb , Zagreb , Croatia. 5. e Research Department , Children's Hospital Srebrnjak , Zagreb , Croatia.
Abstract
OBJECTIVE: Studies show high comorbidity of mood disorders in asthma. As asthma is a highly heterogeneous disease with different phenotypes it can be expected that there is a difference in this association with different asthma phenotypes. The aim of our cross-sectional study was to assess the association of specific asthma phenotypes with anxiety and/or depression and their impact on asthma control. METHODS: A cross-sectional study in 201 consecutive adult outpatients with asthma (≥18 years of age) was conducted. Each patient underwent physical examination, detailed medical history, Hospital Anxiety and Depression Scale, Asthma Control Questionnaire, Asthma Control Test, together with measurements of lung function and fraction of exhaled nitric oxide. Phenotypes were assessed using cluster analysis, and a multivariate analysis was used to identify associations of mood disorders with different phenotypes. RESULTS: Five asthma phenotypes were identified: allergic (AA, 43.8%), aspirin-exacerbated respiratory disease (AERD, 21.9%), late-onset (LOA, 18.9%), obesity-associated (OAA, 10.0%), and respiratory infections associated asthma (RIAA, 5.5%). A multivariate analysis showed a significant association of anxiety with LOA and comorbid hypertension (LOA, odds ratio (OR) = 2.12; hypertension, OR = 2.37, p = 0.012), and depression with AA, RIAA, hypertension, and ACQ score (AA, OR = 6.07; RIAA, OR = 4.73; hypertension, OR = 5.67; ACQ, OR = 1.87; p < 0.001). Comorbid anxiety/depression was associated with AA, LOA, RIAA, hypertension, and ACQ score (AA, OR = 10.15; LOA, OR = 2.98; RIAA, OR = 6.29; hypertension, OR = 5.15; ACQ, OR = 1.90; p < 0.001. CONCLUSION: Mood disorders were significantly associated with AA, LOA, and infection-associated asthma, together with comorbid hypertension and the level of asthma control.
OBJECTIVE: Studies show high comorbidity of mood disorders in asthma. As asthma is a highly heterogeneous disease with different phenotypes it can be expected that there is a difference in this association with different asthma phenotypes. The aim of our cross-sectional study was to assess the association of specific asthma phenotypes with anxiety and/or depression and their impact on asthma control. METHODS: A cross-sectional study in 201 consecutive adult outpatients with asthma (≥18 years of age) was conducted. Each patient underwent physical examination, detailed medical history, Hospital Anxiety and Depression Scale, Asthma Control Questionnaire, Asthma Control Test, together with measurements of lung function and fraction of exhaled nitric oxide. Phenotypes were assessed using cluster analysis, and a multivariate analysis was used to identify associations of mood disorders with different phenotypes. RESULTS: Five asthma phenotypes were identified: allergic (AA, 43.8%), aspirin-exacerbated respiratory disease (AERD, 21.9%), late-onset (LOA, 18.9%), obesity-associated (OAA, 10.0%), and respiratory infections associated asthma (RIAA, 5.5%). A multivariate analysis showed a significant association of anxiety with LOA and comorbid hypertension (LOA, odds ratio (OR) = 2.12; hypertension, OR = 2.37, p = 0.012), and depression with AA, RIAA, hypertension, and ACQ score (AA, OR = 6.07; RIAA, OR = 4.73; hypertension, OR = 5.67; ACQ, OR = 1.87; p < 0.001). Comorbid anxiety/depression was associated with AA, LOA, RIAA, hypertension, and ACQ score (AA, OR = 10.15; LOA, OR = 2.98; RIAA, OR = 6.29; hypertension, OR = 5.15; ACQ, OR = 1.90; p < 0.001. CONCLUSION:Mood disorders were significantly associated with AA, LOA, and infection-associated asthma, together with comorbid hypertension and the level of asthma control.
Authors: Amira M Aker; Anne L Stephenson; Andrew S Wilton; Simone N Vigod; Cindy-Lee Dennis; Astrid Guttmann; Hilary K Brown Journal: Can J Psychiatry Date: 2021-08-26 Impact factor: 5.321
Authors: Alexandra Kulikova; Josseline Lopez; Anna Antony; Dave A Khan; Donna Persaud; Jasmine Tiro; Elena I Ivleva; Alyson Nakamura; Zena Patel; Shane Tipton; Tressa Lloyd; Karen Allen; Savitoj Kaur; M Seth Owitz; Ray J Pak; Michael S Adragna; Raymond Chankalal; Quratulain Humayun; Heather K Lehman; Bruce D Miller; Beatrice L Wood; E Sherwood Brown Journal: J Allergy Clin Immunol Pract Date: 2021-03-04
Authors: Gustaf Rejnö; Cecilia Lundholm; Sara Öberg; Paul Lichtenstein; Henrik Larsson; Brian D'Onofrio; Kjell Larsson; Sissel Saltvedt; Bronwyn K Brew; Catarina Almqvist Journal: Sci Rep Date: 2019-09-11 Impact factor: 4.379
Authors: Abdullah M M Alanazi; Mohammed M Alqahtani; Gregory Pavela; Eric W Ford; Adam M Leventhal; Peter S Hendricks Journal: Int J Environ Res Public Health Date: 2020-11-26 Impact factor: 3.390